Contents of this document
- Average exchange rate158 JPY/USD
- Middle East situationDetailsAssumed to normalize from the second quarter onward
- Naphtha price assumed in the three-year medium-term management plan¥70,000 /kl
- Exchange rate assumed in the three-year medium-term management plan140 JPY/USD
- Expansion of production facilities for the food packaging materials business and expansion of the Mie Plant
- Expansion of thermoplastic elastomer compound production facilities
- Expansion of production facilities for food packaging film
- Plan to expand the Mie Plant through the acquisition of adjacent land
- Installation of solar power generation facilities in Thailand and Vietnam
- Introduction of a Shareholder Benefit Program
- Launch of sales of cable materials for ADAS applications
- Launch of sales of new products for the outpackaging market
- Joint research and collaboration with Shimane University, Niihama National Institute of Technology, and startup companies
- ROS8.7 %Year on year against the same period last year+0.5 percentage points year on year
- ROE11.4 %Year on year against the same period last year±0.0 percentage points
- ROIC11.7 %Year on year against the same period last year+0.7 percentage points
- EBITDA¥15,676 millionYear on year against the same period last year+7.5%
- New products as a percentage of revenue15 %Year on year against the same period last year+5 percentage points
- Number of companies with which IR/SR meetings were held174 companiesYear on year against the same period last year169 companies in the previous fiscal year
- Revenue from compounds and films for automotive wire applications¥250 100 millionYear on year against the same period last year+6.3%
- Compound consumption by Japanese wire-harness manufacturers82 thousand tonnesYear on year against the same period last yearMarket growth: -3.2%
- Revenue from compounds for automotive molded components¥156 100 millionYear on year against the same period last year+3.7%
- Dialysis circuit sales volume99 million sets
- Revenue from medical compounds¥466 100 millionYear on year against the same period last year+3.1%
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Fiscal year ending March 2026, full-year results |
| Net Sales | ¥131,377 million (YoY +2.5%) |
| Operating profit | ¥11,408 million (YoY +8.8%) |
| Ordinary income | ¥11,786 million (YoY +11.3%) |
| Net income | ¥7,569 million (net income attributable to owners of the parent) (YoY +2.7%) |
| Gross Profit Margin | 19.5% (gross profit of ¥25,611 million / revenue of ¥131,377 million; year-on-year change not disclosed in the materials) |
| Operating profit margin | 8.7%, up 0.5 percentage points year on year |
| Full-year earnings forecast | Fiscal year ending March 2027 Net Sales ¥142,000 million / Operating profit ¥12,000 million / Ordinary income ¥12,000 million / Net income ¥6,800 million (net income attributable to owners of the parent) / Earnings per share ¥142.89 / ROS 8.5 % / ROE 9.8 % / ROIC 11.8 % / EBITDA ¥16,900 million / Average exchange rate 158 JPY/USD |
| Segment results | Transportation Net Sales ¥42,842 million / Profit ¥4,456 million / Year-on-year sales +4.2% / Year-on-year change in profit -8.5% / Daily Life & Healthcare Net Sales ¥36,474 million / Profit ¥3,941 million / Year-on-year sales -0.9% / Year-on-year change in profit +11.9% / Electronics Net Sales ¥25,692 million / Profit ¥1,835 million / Year-on-year sales +4.1% / Year-on-year change in profit +87.7% / Building & Construction Net Sales ¥26,333 million / Profit ¥1,041 million / Year-on-year sales +3.5% / Year-on-year change in profit +2.9% |
| Breakdown of Factors Affecting the Change | Year-on-year change in operating profit Appropriate sales price adjustments and timing differences: +¥2,160 million; higher sales volumes: +¥89 million; foreign exchange effects: +¥77 million; higher logistics costs: -¥174 million; higher depreciation and amortization, etc.: -¥368 million; higher personnel expenses: -¥865 million / Change in operating profit versus initial forecast Appropriate sales price adjustments and timing differences: +¥1,272 million; foreign exchange effects: +¥371 million; selling, general and administrative expense reductions: +¥252 million; sales volumes below target: -¥986 million |
| Key KPIs | Indicator name ROS / Value 8.7 % / Year on year against the same period last year +0.5 percentage points year on year, Indicator name ROE / Value 11.4 % / Year on year against the same period last year ±0.0 percentage points, Indicator name ROIC / Value 11.7 % / Year on year against the same period last year +0.7 percentage points, Indicator name EBITDA / Value ¥15,676 million / Year on year against the same period last year +7.5%, Indicator name New products as a percentage of revenue / Value 15 % / Year on year against the same period last year +5 percentage points, Indicator name Number of companies with which IR/SR meetings were held / Value 174 companies / Year on year against the same period last year 169 companies in the previous fiscal year |
| Unit price and quantity metrics | Indicator name Revenue from compounds and films for automotive wire applications / Value ¥250 100 million / Year on year against the same period last year +6.3%, Indicator name Compound consumption by Japanese wire-harness manufacturers / Value 82 thousand tonnes / Year on year against the same period last year Market growth: -3.2%, Indicator name Revenue from compounds for automotive molded components / Value ¥156 100 million / Year on year against the same period last year +3.7%, Indicator name Dialysis circuit sales volume / Value 99 million sets / Year on year against the same period last year Not disclosed, Indicator name Revenue from medical compounds / Value ¥466 100 million / Year on year against the same period last year +3.1% |
| Assumptions Underlying the Business Outlook | Item Average exchange rate / Value 158 JPY/USD, Item Middle East situation / Details Assumed to normalize from the second quarter onward, Item Naphtha price assumed in the three-year medium-term management plan / Value ¥70,000 /kl, Item Exchange rate assumed in the three-year medium-term management plan / Value 140 JPY/USD |
| Medium-term management plan targets | Target fiscal year Fiscal year ending March 2028 / Net Sales ¥142,000 million / ROS 8 % / ROE 10 % / ROIC 11 % / EBITDA ¥17,000 million / New products as a percentage of revenue 23 % |
| Financial targets | ROE Target value >=10.0% / Actual value 11.4 % / ROIC Target value >=11.0% / Actual value 11.7 % / PBR Target value >=1.0x / Actual value 1.17 times |
| Annual Dividend | Annual dividend per share ¥54 / Breakdown Interim and year-end breakdown: Not disclosed |
| Payout ratio | 35.1 % |
| Acquisition of treasury shares | Number of shares acquired 372 / Share unit 10,000 shares / Total acquisition price 45 / Amount unit ¥100 million / Period Not disclosed / Cancellation All acquired shares are scheduled to be cancelled; 2 million shares were cancelled on 30 June 2025 |
| Capital expenditures | ¥140 100 million (total investment in major domestic plants) |
| Market Size / Share | The materials compare market size, market growth rates, and the company's revenue across multiple fields. Market share figures: not disclosed |
| New initiatives | Expansion of production facilities for the food packaging materials business and expansion of the Mie Plant, Expansion of thermoplastic elastomer compound production facilities, Expansion of production facilities for food packaging film, Plan to expand the Mie Plant through the acquisition of adjacent land, Installation of solar power generation facilities in Thailand and Vietnam, Introduction of a Shareholder Benefit Program, Launch of sales of cable materials for ADAS applications, Launch of sales of new products for the outpackaging market, Joint research and collaboration with Shimane University, Niihama National Institute of Technology, and startup companies |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Profit increased by ¥2,160 million from the effects of appropriate sales price adjustments and timing differences, ¥89 million from higher sales volumes, and ¥77 million from foreign exchange effects. These gains were partly offset by higher logistics costs, depreciation and amortization, and personnel expenses.